NEW YORK STATE COMMON RETIREMENT FUND - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 121 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$202,000
+23.2%
21,5000.0%0.00%
Q2 2020$164,000
+23.3%
21,5000.0%0.00%
Q1 2020$133,000
-66.7%
21,500
-34.5%
0.00%
Q4 2019$399,000
+5.3%
32,8000.0%0.00%
Q3 2019$379,000
+15.5%
32,8000.0%0.00%
Q2 2019$328,000
-22.3%
32,8000.0%0.00%
-100.0%
Q1 2019$422,000
-15.3%
32,8000.0%0.00%0.0%
Q4 2018$498,000
-35.2%
32,800
-14.6%
0.00%0.0%
Q3 2018$768,000
-10.5%
38,400
-12.7%
0.00%0.0%
Q2 2018$858,000
-3.3%
44,0000.0%0.00%0.0%
Q1 2018$887,000
+52.1%
44,0000.0%0.00%0.0%
Q4 2017$583,000
-22.8%
44,000
+7.6%
0.00%0.0%
Q3 2017$755,000
+0.3%
40,9000.0%0.00%0.0%
Q2 2017$753,000
-18.3%
40,900
-0.0%
0.00%0.0%
Q1 2017$922,000
-79.6%
40,901
-68.5%
0.00%
-83.3%
Q4 2016$4,513,000
+379.6%
129,675
+237.7%
0.01%
+500.0%
Q3 2016$941,000
+2.4%
38,4000.0%0.00%0.0%
Q2 2016$919,000
-38.5%
38,400
-39.9%
0.00%
-50.0%
Q1 2016$1,494,000
-22.5%
63,8530.0%0.00%
-33.3%
Q4 2015$1,928,000
-63.1%
63,853
-51.5%
0.00%
-62.5%
Q3 2015$5,232,000
+5.1%
131,688
+82.8%
0.01%
+14.3%
Q2 2015$4,976,000
+541.2%
72,051
+407.4%
0.01%
+600.0%
Q1 2015$776,000
+28.3%
14,2000.0%0.00%0.0%
Q4 2014$605,00014,2000.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
HealthInvest Partners AB 520,000$15,699,0007.39%
Palo Alto Investors LP 2,835,792$85,613,0004.76%
Opaleye Management Inc. 150,000$4,529,0001.89%
Engaged Capital LLC 61,425$1,854,0001.15%
IRONWOOD INVESTMENT MANAGEMENT LLC 91,400$2,759,0001.14%
Endurant Capital Management LP 111,180$3,357,0001.12%
AlphaOne Investment Services, LLC 86,817$2,621,0000.94%
ASHFORD CAPITAL MANAGEMENT INC 127,625$3,853,0000.91%
ARDSLEY ADVISORY PARTNERS LP 205,000$6,189,0000.81%
STELLIAM INVESTMENT MANAGEMENT, LP 685,000$20,680,0000.62%
View complete list of AMAG PHARMACEUTICALS INC shareholders